by admin | May 9, 2024 | News & Opinions
By Franny White – OHSU News – About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published today in the...
by admin | May 8, 2024 | News & Opinions
by Michelle Jaffee – Main St. Daily News – In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and...
by admin | May 7, 2024 | News & Opinions
by Elena Garrido – Neuroscience News – Researchers uncovered a crucial mechanism in brain stem cells that prevents identity conflicts during gene expression, enabling these cells to maintain stemness while being primed for neuronal differentiation. The...
by admin | May 4, 2024 | News & Opinions
By Ewen Callaway – Nature – Some of the AI-designed gene editors could be more versatile than those found in nature. In the never-ending quest to discover previously unknown CRISPR gene-editing systems, researchers have scoured microbes in everything from...
by admin | May 2, 2024 | News & Opinions
by Moffit Cancer Center – TAMPA, Fla. — Cells constantly navigate a dynamic environment, facing ever-changing conditions and challenges. But how do cells swiftly adapt to these environmental fluctuations? A new Moffitt Cancer Center study, published in iScience,...
by admin | May 1, 2024 | News & Opinions
By Patrick O’Neill – ISS National Laboratory – KENNEDY SPACE CENTER (FL), April 30, 2024 – Research on a novel vision loss therapy and space-manufactured optical fibers were among the nearly 565 pounds of science and technology payloads sponsored by the...
